(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HEALTHCARE ANYWHERE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

HEALTHCARE ANYWHERE

ST13

US500000090792233

Class

44

Filing

90792233

Registration

7237084

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

12/05/2023

Classification

Registered

Trademark type

Word

Nice classes

44

Filing date

06/24/2021

Registration date

12/05/2023

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/05/2023

Last transaction

12/05/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/10/2023

First use in commerce

05/10/2023

Drawing code

4

Owner type

16

Owner location

Scottsdale, AZ

Examiner

JANSON, ANDREW

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Priority Ambulance, LLC

Representatives

Conrad Pitts

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Telemedicine services; telemedicine services provided as an integrated service with the emergency and non-emergency ambulance transport services of others

Publications

History of USPTO decisions and trademark events.

31 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/05/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

12/05/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/31/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/30/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/18/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/18/2023

IUAF

USE AMENDMENT FILED

10/05/2023

EISU

TEAS STATEMENT OF USE RECEIVED

10/05/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/29/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/04/2023

PUBO

PUBLISHED FOR OPPOSITION

07/04/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/14/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/01/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/25/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/24/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/24/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/24/2022

GNRT

NON-FINAL ACTION E-MAILED

10/24/2022

CNRT

NON-FINAL ACTION WRITTEN

10/24/2022

NREV

NOTICE OF REVIVAL - E-MAILED

10/11/2022

PETG

PETITION TO REVIVE-GRANTED

10/11/2022

PROA

TEAS PETITION TO REVIVE RECEIVED

10/11/2022

MAB2

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

10/07/2022

MAB2

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

10/07/2022

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

10/07/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/22/2022

GNRT

NON-FINAL ACTION E-MAILED

03/22/2022

CNRT

NON-FINAL ACTION WRITTEN

03/22/2022

DOCK

ASSIGNED TO EXAMINER

03/16/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/08/2021

NWAP

NEW APPLICATION ENTERED

06/28/2021

Continuous trademark protection

Get notified about every new filing that threatens HEALTHCARE ANYWHERE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.